Acne vulgaris: role of the immune system
- 11 January 2021
- journal article
- review article
- Published by Wiley in International Journal of Dermatology
- Vol. 60 (9) , 1076-1081
Abstract
Acne vulgaris is a worldwide condition that has a complex pathophysiology. The knowledge of this pathology is clear in its four classic principles based on the pilosebaceous unit; there exists hyperkeratinization of its duct, increase of sebum production, anaerobic bacterias, and inflammatory response. However, new findings have explained the relationship that occurs inside the acne lesion. The immune system has a key role since it is stimulated by the other participants involved, such as phylotypes of Propionibacterium acnes (P. acnes), antimicrobial peptides (AMPs), sebaceous glands (SGs), matrix metalloproteinases (MMPs), and other immune system pathways.Keywords
This publication has 31 references indexed in Scilit:
- What's new in the physiopathology of acne?British Journal of Dermatology, 2015
- A global perspective on the epidemiology of acneBritish Journal of Dermatology, 2015
- Understanding innate immunity and inflammation in acne: implications for managementJournal of the European Academy of Dermatology and Venereology, 2015
- IL-17/Th17 Pathway Is Activated in Acne LesionsPLOS ONE, 2014
- Propionibacterium acnes Induces IL-1β Secretion via the NLRP3 Inflammasome in Human MonocytesJournal of Investigative Dermatology, 2014
- Acne is an inflammatory disease and alterations of sebum composition initiate acne lesionsJournal of the European Academy of Dermatology and Venereology, 2013
- Analysis of distribution patterns ofPropionibacterium acnesphylotypes andPeptostreptococcusspecies from acne lesionsBritish Journal of Dermatology, 2013
- Systemic Isotretinoin Therapy Normalizes Exaggerated TLR-2-Mediated Innate Immune Responses in Acne PatientsJournal of Investigative Dermatology, 2012
- Immune functions of the skinClinics in Dermatology, 2011
- Sebum Free Fatty Acids Enhance the Innate Immune Defense of Human Sebocytes by Upregulating β-Defensin-2 ExpressionJournal of Investigative Dermatology, 2010